Abstract:The type II-A CRISPR effector SpCas9 has gained widespread popularity as an efficient and programmable genome editing tool. However, much remains to be known about novel compact variants that may overcome some limitations of current systems . Recently, alternative CRISPR-Cas systems with highly compact nucleases capable of genome editing in mammalian cells have been discovered through metagenomic analysis of uncultivated microbes, including Cas9d (a type II-D CRISPR-Cas effector) . Here, we report the cryo-EM structures of a Cas9d nuclease (747 amino acids in length) in multiple functional states, revealing a stepwise process of DNA targeting involving a conformational switch in a REC2 domain insertion. Our structures provide insights into the intricately folded guide RNA which acts as a structural scaffold to anchor small, flexible protein domains and facilitate DNA target recognition. We find that the sgRNA can be truncated by up to ∼25% yet still retain activity . We also show that despite preferentially targeting an NGG PAM, Cas9d exhibits a unique mechanism for PAM recognition. Finally, we identify the first Cas9d smaller than 800 amino acids exhibiting robust nuclease activity in mammalian cells. Using ancestral sequence reconstruction, we demonstrate that it is possible to generate compact nucleases capable of efficient genome editing by expanding the diversity of Cas9d families. Collectively, our results provide mechanistic insights into the evolution and DNA targeting of diverse type II CRISPR-Cas systems, providing a molecular blueprint for future rational re-engineering of minimal RNA-guided DNA nucleases.

CoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing

Genome editing with natural and engineered CjCas9 orthologs

DNA targeting by compact Cas9d and its resurrected ancestor

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Compact SchCas9 Recognizes the Simple NNGR PAM

Eukaryotic-driven directed evolution of Cas9 nucleases

Programmed genome editing by a miniature CRISPR-Cas12f nuclease

Rationally designed Campylobacter jejuni Cas9 enables efficient gene activation and base editing

Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9

FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity

Engineered CRISPR-Cas9 nuclease with expanded targeting space

CRISPR/Cas9 in Genome Editing and Beyond

Engineered Campylobacter jejuni Cas9 variant with enhanced activity and broader targeting range

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity

Multiplex Genome Engineering Using CRISPR/Cas Systems

Expanding the CRISPR toolbox by engineering Cas12a orthologs of metagenomic discovery

Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems

In vivo genome editing using Staphylococcus aureus Cas9

Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing

Discovery and engineering of small SlugCas9 with broad targeting range and high specificity and activity